Xuben T. Hou
44 West Wenhua Road
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Targeting SIRT6: the design and therapeutic implications of activators and inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: June 21, 2026
Discovery of Benzofuran-2-Carboxylic Acid Derivatives as Potent PTPRO Inhibitors with Oral Efficacy for Treatment of Inflammatory Bowel Disease.
Journal: Journal of medicinal chemistry
Published: April 28, 2026
WeMol: A Cloud-Based and Zero-Code Platform for AI-Driven Molecular Design and Simulation.
Journal: Journal of chemical information and modeling
Published: February 11, 2026
Targeting N1-methyladenosine modification in osteoblasts through tRNA methyltransferase 10C reverses mitochondrial dysfunction and ameliorates osteoporosis.
Journal: Signal transduction and targeted therapy
Published: November 04, 2025
Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitors.
Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: October 01, 2025
Label-free fluorescence lateral flow biosensing platform based on host-guest recognition for on-site detection of amantadine in egg samples.
Journal: Food chemistry
Published: September 23, 2025
Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers.
Journal: MedComm
Published: August 20, 2025
A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticle.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 07, 2025
Optimizing pyrazine-2-carboxamide derivatives as dual FLT3/HDAC inhibitors with enhanced pharmacokinetics and immunotherapeutic potential.
Journal: Acta pharmaceutica Sinica. B
Published: June 16, 2025
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.
Journal: Signal transduction and targeted therapy
Published: May 29, 2025
Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screening.
Journal: European journal of medicinal chemistry
Published: May 23, 2025
Last Updated: 09/26/2026